Astaxanthin Improves Nonalcoholic Fatty Liver Disease in Werner Syndrome with Diabetes Mellitus

E-ISSN： 1532-5415|63|6|1271-1273

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.63, Iss.6, 2015-06, pp. : 1271-1273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non‐alcoholic fatty liver disease

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E42-E51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five‐year cohort study

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 11, 2015-11 ,pp. : 2401-2407

John Wiley & Sons Inc

Access to resources Recommend Favorite

Practical approach to non‐alcoholic fatty liver disease in patients with diabetes

DIABETIC MEDICINE, Vol. 32, Iss. 9, 2015-09 ,pp. : 1121-1133

John Wiley & Sons Inc

Access to resources Recommend Favorite

Common Features of the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease

Reviews on Recent Clinical Trials, Vol. 9, Iss. 3, 2014-09 ,pp. : 148-158

Bentham Science Publishers

Access to resources Recommend Favorite

Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non‐alcoholic fatty liver disease: A prospective randomized controlled pilot study

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 438-442

John Wiley & Sons Inc

Access to resources Recommend Favorite